GlassScriptPhysician profile
Eugene E Ruckh
NPI 1851352082
$1,665.67
in general payments reported to CMS, 2019-2025
19 companies · $31.78 in 2025
The $31.78 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $383 · 2021: $140 · 2022: $259 · 2023: $38.10 · 2024: $25.00 · 2025: $31.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $636.12 | 2019-2025 | Grafix Pl |
| Organogenesis INC. | $247.86 | 2019-2022 | |
| Integra Lifesciences Corporation | $136.58 | 2020 | |
| Derma Sciences, INC. | $132.41 | 2019 | |
| Osiris Therapeutics INC. | $107.94 | 2019 | |
| Kci USA, INC. | $88.31 | 2019 | |
| Tei Medical INC. | $53.43 | 2019 | |
| Horizon Therapeutics Plc | $45.50 | 2020-2021 | |
| Triad Life Sciences INC. | $38.32 | 2022 | |
| Nabriva Therapeutics, Plc | $36.08 | 2022 | |
| Medtronic, INC. | $25.51 | 2022 | |
| Next Science LLC | $25.00 | 2024 | Blastx, Surgx, Xperience |
| Progenacare Global, LLC | $24.60 | 2023 | |
| Cashflow Solutions, LLC | $13.50 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Merck Sharp & Dohme LLC | $12.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.30 | 2022 | |
| Melinta Therapeutics, LLC | $12.09 | 2019 | |
| Kerecis Limited | $9.24 | 2021 | |
| Reprise Biomedical, INC. | $8.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Ruckh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.